Company news
Eirgenix, Inc. (TWSE:6589) news
Eirgenix, Inc. news releases on 6ix. Latest, Dec 28, 2025: Transcenta Therapeutics Announces Strategic Collaboration and Non-exclusive Licensing Agreement…
Press releases & updates
Transcenta Therapeutics Announces Strategic Collaboration and Non-exclusive Licensing Agreement to Advance Integrated Continuous Biomanufacturing and Expand Global Access to Affordable Biologics
December 27, 2025
/C O R R E C T I O N -- EirGenix, Inc./
November 12, 2025
EirGenix Signed The Commercial Licensinse Agreement for It's Second HER2 Biosimilar Asset EG1206A
November 12, 2025
EirGenix : The Company’s Board of Directors Resolved to Issue Employee Stock Warrants.
August 11, 2022
EirGenix : Announcement of Board approve the permission of managers for competitive actions.
August 11, 2022
EirGenix : The Board of Directors Appointed the 3rd term Remuneration Committee Member.
August 11, 2022
EirGenix : Announcement of the Construction Design and Consulting Fee for New Plant.
August 11, 2022
EirGenix : Announcement of the Production Line Expansion and Production Equipment at Zhubei Facility. (Budget Increase)
August 11, 2022
EirGenix : Announcement of the tenure expired of Remuneration Committee of 2nd Board of Directors.
June 10, 2022
EirGenix : Announcement of the appointment of the 3rd term Audit Committee members.
June 10, 2022
EirGenix : Announcement of AGM's approval of suspension of the non-competition restriction on the 5th directors or representatives of directors.
June 10, 2022
EirGenix : Shareholders Elect Board of Directors; Board of Directors Unanimously Elect Dr. Lee-Cheng Liu as Chairman.
June 10, 2022
EirGenix : Important resolutions of EirGenix's 2022 Annual Shareholders' Meeting.
June 10, 2022
EirGenix : Announcement of Election of Directors at 2022 Annual Shareholders’Meeting.
June 10, 2022
EirGenix : Announcement of the Board of Directors resolved to update the vesting conditions of employee restricted stock awards in 2022.
April 19, 2022
EirGenix : Announcement of Completion of the Capital Reduction Registration due to the RSA Write-off
April 18, 2022
EirGenix : Announcement for Replacement of Representative of Juristic Person as Director.
March 29, 2022
EirGenix : Announcement of the Board of Directors resolution of the issuance of the private placement of securities.
March 22, 2022
EirGenix : Announcement of the Board of Directors resolution of the convening of the 2022 Annual Shareholders' Meeting.
March 22, 2022
EirGenix : Announcement of the Board of Directors Resolution on the first issuance of new shares for employee restricted stock awards in 2022.
March 22, 2022
EirGenix : The Board of Directors resolved not to distribute dividends.
March 22, 2022
EirGenix : Announcement of the Board of Directors approval of the cancellation of restricted shares to employee stock awards.
March 22, 2022
EirGenix : To announce the acquisition of major assets.
March 9, 2022